Angelalign Technology Inc. Just Recorded A 7.8% Revenue Beat: Here's What Analysts Think

It's been a good week for Angelalign Technology Inc. (HKG:6699) shareholders, because the company has just released its latest interim results, and the shares gained 9.2% to HK$71.80. It was a workmanlike result, with revenues of US$161m coming in 7.8% ahead of expectations, and statutory earnings per share of US$0.09, in line with analyst appraisals. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Taking into account the latest results, the consensus forecast from Angelalign Technology's eleven analysts is for revenues of US$338.3m in 2025. This reflects a solid 9.5% improvement in revenue compared to the last 12 months. Statutory earnings per share are forecast to nosedive 49% to US$0.07 in the same period. Before this earnings report, the analysts had been forecasting revenues of US$322.2m and earnings per share (EPS) of US$0.088 in 2025. While next year's revenue estimates increased, there was also a large cut to EPS expectations, suggesting the consensus has a bit of a mixed view of these results.

See our latest analysis for Angelalign Technology

Curiously, the consensus price target rose 6.2% to HK$83.02. We can only conclude that the forecast revenue growth is expected to offset the impact of the expected fall in earnings. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Angelalign Technology analyst has a price target of HK$104 per share, while the most pessimistic values it at HK$66.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The period to the end of 2025 brings more of the same, according to the analysts, with revenue forecast to display 20% growth on an annualised basis. That is in line with its 19% annual growth over the past three years. Juxtapose this against our data, which suggests that other companies (with analyst coverage) in the industry are forecast to see their revenues grow 17% per year. It's clear that while Angelalign Technology's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. There was also an upgrade to revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Angelalign Technology analysts - going out to 2027, and you can see them free on our platform here.

We also provide an overview of the Angelalign Technology Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.